Search
decreased serum IgG responses to NTHi outer membrane proteins may contribute to the development of chronic and severe OM in Australian Aboriginal children
Our research focuses on what are the best ways for patients with Type 1 Diabetes to exercise safely. We aim to develop clinical guidelines that provide improved advice for patients and educate patients on how to prevent hypos during and after exercise.
Advances in understanding bacterial dynamics in the upper airway microbiome are driving development of microbiota-modifying therapies to prevent or treat disease
This study will tell us if the use of a hybrid closed loop system can improve awareness of hypoglycaemia.
The aim of this study was to assess the relationship between dust levels and health in Indigenous children in Western Australia
The national Hybrid Closed-Loop Outpatient Trial will test the use of an automated insulin delivery system to see if it is better at optimising blood glucose levels than standard therapy.
Infant vaccination with 3 doses of PCV10 or PCV13 is safe and immunogenic in a highly endemic setting
Our findings suggest that utilization of IL-7 by cTFH cells affects production of IgG2 antibodies to PPV23 antigens in some HIV patients
This resource will allow researchers to carry out studies which will look at the genetic causes of excessive weight gain and identify biomarkers
Combining elevated CRP with the presence or absence of clinical signs/ symptoms differentiates definite bacterial from presumed viral pneumonia better than CRP alone
The Obesity Database records the characteristics and medical complications of children with obesity who present to treatment at Princess Margaret Hospital
PPV is immunogenic in 9-month-old children at high risk of pneumococcal infections and does not affect the capacity to produce protective immune responses
This register was established at Princess Margaret Hospital in 1987 which stores data on all consenting patients attending the hospital’s diabetes clinic.
Pneumonia is the leading cause of childhood morbidity and mortality globally.
The Serum & Plasma bank was established to provide a store of samples from subjects with diabetes as well as their families.
Peter Richmond MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials Group
Collecting DNA samples from Australian families affected by diabetes.
The year 2013 saw the progress in our research from purely lab-based studies towards taking a step closer to translational research.
We are studying exercise in young people with T2DM and obese young people at risk of developing type 2 diabetes